# | Title | Journal | Year | Citations |
---|
1 | Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase | Journal of Bacteriology | 1994 | 348 |
2 | Morphogenesis ofFilobasidiella Neoformans, the Sexual State ofCryptococcus Neoformans | Mycologia | 1976 | 305 |
3 | Candida glabrata PDR1 , a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants | Antimicrobial Agents and Chemotherapy | 2006 | 216 |
4 | A New Species ofFilobasidiella, The Sexual State ofCryptococcus NeoformansB and C Serotypes | Mycologia | 1976 | 214 |
5 | Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis | Antimicrobial Agents and Chemotherapy | 2004 | 205 |
6 | Galactomannan Antigenemia and Antigenuria in Aspergillosis: Studies in Patients and Experimentally Infected Rabbits | Journal of Infectious Diseases | 1987 | 158 |
7 | Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1 , in Candida glabrata | Antimicrobial Agents and Chemotherapy | 1998 | 155 |
8 | Update on Azole Antifungals | Seminars in Respiratory and Critical Care Medicine | 2008 | 148 |
9 | Morphogenesis of Filobasidiella neoformans, the Sexual State of Cryptococcus neoformans | Mycologia | 1976 | 143 |
10 | 5-Fluorocytosine Resistance in Cryptococcus neoformans | Antimicrobial Agents and Chemotherapy | 1973 | 111 |
11 | Successful Treatment of Coccidioidal Meningitis with Voriconazole | Clinical Infectious Diseases | 2003 | 109 |
12 | Echinocandins for Candidemia in Adults without Neutropenia | New England Journal of Medicine | 2006 | 102 |
13 | Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers | Journal of Infectious Diseases | 1991 | 99 |
14 | Antibody-dependent Killing of Cryptococcus neoformans by Human Peripheral Blood Mononuclear Cells | Nature | 1974 | 98 |
15 | Comparison of Isolates of Sporothrix schenckii Obtained from Fixed Cutaneous Lesions with Isolates from Other Types of Lesions | Journal of Infectious Diseases | 1979 | 90 |
16 | Outbreak of Human Parainfluenza Virus 3 Infections in a Hematopoietic Stem Cell Transplant Population | Journal of Infectious Diseases | 2001 | 86 |
17 | Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal Isolates | Antimicrobial Agents and Chemotherapy | 2010 | 77 |
18 | Genetic Analysis of Azole Resistance in the Darlington Strain of Candida albicans | Antimicrobial Agents and Chemotherapy | 2000 | 73 |
19 | Evaluation of reference genes for real-time quantitative PCR studies in Candida glabrata following azole treatment | BMC Molecular Biology | 2012 | 71 |
20 | Phylogenetic Spectrum of Fungi That Are Pathogenic to Humans | Clinical Infectious Diseases | 1994 | 68 |
21 | Flucytosine Monotherapy for Cryptococcosis | Clinical Infectious Diseases | 1998 | 68 |
22 | Function ofCandida glabrata ABC transporter gene,PDH1 | Yeast | 2003 | 60 |
23 | Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients | Bone Marrow Transplantation | 2001 | 57 |
24 | Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography. | Antimicrobial Agents and Chemotherapy | 1991 | 54 |
25 | Clinical Trial of Quantitative Real‐Time Polymerase Chain Reaction for Detection of Cytomegalovirus in Peripheral Blood of Allogeneic Hematopoietic Stem‐Cell Transplant Recipients | Journal of Infectious Diseases | 2003 | 54 |
26 | Forum Report: Issues in Clinical Trials of Empirical Antifungal Therapy in Treating Febrile Neutropenic Patients | Clinical Infectious Diseases | 2003 | 54 |
27 | Candida glabrata erg1 Mutant with Increased Sensitivity to Azoles and to Low Oxygen Tension | Antimicrobial Agents and Chemotherapy | 2004 | 51 |
28 | Efficacies of Fluconazole, Caspofungin, and Amphotericin B inCandida glabrata-Infected p47phox−/−Knockout Mice | Antimicrobial Agents and Chemotherapy | 2002 | 49 |
29 | Persistence of Cryptococcomas on Neuroimaging | Clinical Infectious Diseases | 2000 | 47 |
30 | Fluconazole Treatment Is Effective against a Candida albicans erg3/erg3 Mutant In Vivo Despite In Vitro Resistance | Antimicrobial Agents and Chemotherapy | 2006 | 47 |
31 | Role of maltase in the utilization of sucrose by Candida albicans | Biochemical Journal | 1993 | 46 |
32 | Differences in cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces | Molecular Immunology | 1991 | 45 |
33 | Transcriptional Profiling of Candida glabrata during Phagocytosis by Neutrophils and in the Infected Mouse Spleen | Infection and Immunity | 2013 | 40 |
34 | STB5 Is a Negative Regulator of Azole Resistance in Candida glabrata | Antimicrobial Agents and Chemotherapy | 2013 | 38 |
35 | Administration of potassium iodide to normal volunteers does not increase killing ofSporothrix schenckiiby their neutrophils or monocytes | Medical Mycology | 1990 | 35 |
36 | Immune‐Globulin Prophylaxis of Respiratory Syncytial Virus Infection in Patients Undergoing Stem‐Cell Transplantation | Journal of Infectious Diseases | 2002 | 34 |
37 | 1,4-Oligoglucosides Inhibit the Binding of Aspergillus fumigatus Conidia to Human Monocytes | Journal of Infectious Diseases | 1991 | 33 |
38 | Prion-Forming Ability of Ure2 of Yeasts Is Not Evolutionarily Conserved | Genetics | 2011 | 30 |
39 | Sterol uptake and sterol biosynthesis act coordinately to mediate antifungal resistance in Candida�glabrata under azole and hypoxic stress | Molecular Medicine Reports | 2018 | 25 |
40 | Formation of a minichromosome in Cryptococcus neoformans as a result of electroporative transformation | Current Genetics | 1994 | 23 |
41 | The biochemical basis for the distinction between the two cryptococcus neoformans varieties with CGB medium | Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology | 1986 | 19 |
42 | Salvage Therapy for Aspergillosis | Clinical Infectious Diseases | 2005 | 13 |
43 | Taxonomic clarification ofCladosporium trichoidesEmmons and its subsequent synonyms | Medical Mycology | 1989 | 12 |
44 | Editorial Commentary:Is Real‐Time Polymerase Chain Reaction Ready for Real Use in Detecting Candidemia? | Clinical Infectious Diseases | 2008 | 11 |
45 | Forum Report: Issues in the Evaluation of Diagnostic Tests, Use of Historical Controls, and Merits of the Current Multicenter Collaborative Groups | Clinical Infectious Diseases | 2003 | 10 |
46 | Overview of the Symposium | Clinical Infectious Diseases | 1990 | 9 |
47 | Kre29p is a novel nuclear protein involved in DNA repair and mitotic fidelity in Candida glabrata | Current Genetics | 2006 | 9 |
48 | Forum Report: Issues in the Design of Trials of Drugs for the Treatment of Invasive Aspergillosis | Clinical Infectious Diseases | 2003 | 7 |
49 | The Discovery of Creatinine Assimilation in Cryptococcus neoformans, and Subsequent Work on the Characterization of the Two Varieties of C. neoformans | Zentralblatt Fur Bakteriologie: International Journal of Medical Microbiology | 1991 | 6 |
50 | Milbemycin A4 oxime as a probe of azole transport inCandida glabrata | FEMS Yeast Research | 2014 | 6 |